Cargando…
Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798318/ https://www.ncbi.nlm.nih.gov/pubmed/35117136 http://dx.doi.org/10.21037/tcr.2019.06.39 |
| _version_ | 1784641774613954560 |
|---|---|
| author | Zhang, Yue Wu, Shenhong |
| author_facet | Zhang, Yue Wu, Shenhong |
| author_sort | Zhang, Yue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8798318 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87983182022-02-02 Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma Zhang, Yue Wu, Shenhong Transl Cancer Res Editorial Commentary AME Publishing Company 2019-12 /pmc/articles/PMC8798318/ /pubmed/35117136 http://dx.doi.org/10.21037/tcr.2019.06.39 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Zhang, Yue Wu, Shenhong Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title | Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title_full | Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title_fullStr | Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title_full_unstemmed | Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title_short | Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| title_sort | avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798318/ https://www.ncbi.nlm.nih.gov/pubmed/35117136 http://dx.doi.org/10.21037/tcr.2019.06.39 |
| work_keys_str_mv | AT zhangyue avelumabplusaxitinibvssunitinibforadvancedrenalcellcarcinoma AT wushenhong avelumabplusaxitinibvssunitinibforadvancedrenalcellcarcinoma |